MedPath

UPTRAVI

UPTRAVI

Approved
DIN Number

02451204

Drug Class

Human

Market Date

Apr 21, 2016

Company
HC

Janssen Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02451204
AIG Number0157750006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AC27 SELEXIPAG
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification48:48.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

SELEXIPAGActive
Strength: 1200 MCG
Monograph: SELEXIPAG

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.